Transaction · 0002037144-26-000004
GPCRStructure Therapeutics Inc.
Coll Crespo Blas
Coll Crespo Blas, CMO, reported an open-market or private sale at Structure Therapeutics Inc. involving 4008.000000 shares for an estimated $144872.77. Reported holdings after the transaction were 1157.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Open-market sellSEC transaction code SCMO
- Trade date
- Sep 21, 2026
- Filing date
- Sep 22, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
GPCR price since this filing
Daily closing prices, with the filing date and available return windowsGPCR · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +33.0%1w ago +4.2%1d ago -5.1%
Returns since7d -11.4%30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0002037144-26-000004 American Depositary Shares
- Transaction date
- Sep 21, 2026 Filed Sep 22, 2026, 09:59 PM · 1d delay
- Shares
- 4,008 sh $36.15 per share
- Estimated value
- -$144k Computed from shares × price
- Holdings after
- 1,157 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
CHIEF MEDICAL OFFICER
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
- F2
Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
- F3
Reflects price per share in Ordinary Shares.
- F4
12,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II.
- F5
Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
- F6
The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 30, 2026.
Related transactions
Same SEC filing0 other transactions
Recent company activity
GPCR0 recent txs